Related Experiment Videos
Communication between multiple drug binding sites on P-glycoprotein.
C Martin1, G Berridge, C F Higgins
1Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, United Kingdom.
Molecular Pharmacology
|August 23, 2000
Summary
P-glycoprotein (P-gp) has multiple drug binding sites, not just one. These sites interact allosterically, influencing drug transport and resistance in tumors.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- P-glycoprotein (P-gp), an ATP-binding cassette transporter, confers tumor resistance to cytotoxic drugs.
- Recent studies suggest P-gp has multiple drug-binding sites, challenging the single-site hypothesis.
Purpose of the Study:
- To directly characterize drug interaction sites on P-gp using radioligand-binding techniques.
- To investigate the interactions between multiple drug binding sites on P-gp.
Main Methods:
- Utilized radioligand-binding assays to study drug interactions with P-glycoprotein.
- Classified drugs as substrates (transported by P-gp) or modulators (alter P-gp function).
Main Results:
- Identified a minimum of four distinct drug binding sites on P-gp.
- Classified sites as transport (for translocation) or regulatory (for function modification).
- Observed complex allosteric interactions where drug binding at one site affects others' affinity states.
Conclusions:
- P-glycoprotein possesses multiple interacting drug binding sites with distinct functions.
- These sites exhibit allosteric regulation, switching between high- and low-affinity conformations.
- Findings contribute to a refined model of P-gp transport mechanisms.